BioCentury
ARTICLE | Financial News

Harpoon raises $70M ahead of additional Phase I starts for TriTACs

November 12, 2018 9:02 PM UTC

Harpoon Therapeutics Inc. (South San Francisco, Calif.) raised $70 million in a series C round led by new investor OrbiMed Advisors, as the immunotherapy company gears up to bring two more of its T cell engagers into clinic next year.

Harpoon CFO Georgia Erbez told BioCentury the financing provides about two years of runway...